Name: Edgewise Therapeutics, Inc. (EWTX) Balance Sheet
Creator: FinSpry

Edgewise Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Edgewise Therapeutics, Inc. (EWTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	41.67	86.10	21.99	15.57	104.92
Short-Term Investments	428.50	232.30	329.95	265.22	24.18
Cash & Short-Term Investments	470.17	318.39	351.95	280.79	129.09
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.31	8.60	5.05	2.98	0.55
Total Current Assets	475.48	327.00	357.00	283.77	129.65
Non-Current Assets
Property, Plant & Equipment (Net)	11.07	12.69	9.85	0.91	0.52
Other Non-Current Assets	0.26	0.35	0.25	0.55	0.28
Total Non-Current Assets	11.33	13.04	10.10	1.46	0.00
Total Assets	486.82	340.04	367.10	285.23	131.14
Current Liabilities
Accounts Payable	5.58	4.03	6.11	3.84	1.58
Short-Term Debt	1.00	0.00	0.00	0.00	0.00
Accrued Liabilities	17.29	6.07	5.84	6.68	2.31
Other Current Liabilities	17.29	5.70	4.03	2.80	0.45
Total Current Liabilities	23.86	16.77	16.59	10.52	4.34
Non-Current Liabilities
Long-Term Debt	3.74	4.43	3.80	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.33	0.00
Total Non-Current Liabilities	3.74	4.43	3.80	0.33	0.00
Total Liabilities	27.60	21.21	20.39	10.85	4.34
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-378.58	-244.76	-144.60	-76.96	-34.15
Accumulated Other Comprehensive Income	0.42	0.10	-1.36	-0.51	0.00
Additional Paid-in Capital	837.36	563.49	492.67	351.85	0.00
Shares Outstanding	94.84	70.45	63.26	49.50	0.00
Total Stockholders' Equity	459.22	318.83	346.72	274.38	126.79
Total Liabilities & Equity	486.82	340.04	367.10	285.23	0.00